Pan Pacific Lymphoma Conference

Pan Pacific Lymphoma Conference

 

More Than 20 Years of Educational Excellence

The Pan Pacific Lymphoma Conference is one of the largest gatherings of clinicians and researchers specializing in the areas of lymphoma and transplantation. The 2021 event is your chance to explore vital information on clinical updates and research, meet key thought leaders, and exchange ideas with more than 500 members of the multidisciplinary lymphoma clinical team including oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists


Conference Venue

Fairmont Orchid

1 North Kaniku Drive
Kohala Coast, HI 96743

Fairmont Orchid Hawaii

Conference Objectives

At the conclusion of the conference, the attendee should be better able to:

  1. Evaluate results of clinical trials with current and emerging agents and regimens to develop evidence-based clinical management strategies in patients with Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL)
  2. Formulate evidence-based management strategies for the optimal management of patients with lymphoma, leukemia, and myeloma, inclusive of multi-modality therapies and maintenance-based regimens
  3. Analyze underlying molecular and cytogenetic abnormalities contributing to hematologic malignancies and their impact on diagnosis, prognosis, and therapeutic approaches
  4. Evaluate the optimal patient selection, timing, and regimen for stem cell transplant and CAR-T cell therapy for patients with lymphoma
  5. Personalize the treatment of hematologic malignancies based upon patient and disease-specific characteristics, and manage treatment-related adverse effects appropriately
  6. Provide accurate and appropriate counsel as part of the treatment plan
  7. Review factors that impact patient selection, availability, and enrollment into clinical trials, examining novel agents under investigation in patients with lymphoma, leukemia, and myeloma

Conference Directors

image-armitage.jpg James O. Armitage, MD
Joe Shapiro Professor of Medicine
Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
image-lunning.jpg Matthew A. Lunning, DO, FACP
Associate Professor
Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
image-peetz.jpg Robbe L. Peetz, MMS, PA-C
Advanced Practice Provider Manager Cancer Services
Nebraska Medicine
image-roeder.jpg Tawny J. Roeder, RN, BSN, BMTCN
Case Manager, Blood and Marrow Transplantation
Division of Oncology and Hematology
Department of Internal Medicine
Nebraska Medicine
image-vose.jpg Julie M. Vose, MD, MBA
Neumann M. and Mildred E. Harris Professor
Chief, Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
   

Sponsors

This conference is sponsored by the UNMC Department of Internal Medicine – Division of Oncology and Hematology, with the UNMC Center for Continuing Education, UNMC College of Nursing Continuing Nursing Education and Postgraduate Institute for Medicine.